Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPLP0P4, or "ribosomal protein lateral stalk subunit P0 pseudogene 4," is a **pseudogene** related to the functional ribosomal protein lateral stalk subunit P0 (RPLP0). As a pseudogene, **RPLP0P4 does not code for a functional protein** and is not considered a therapeutic target or a conventional molecular target in drug discovery. Ribosomal protein lateral stalk subunit P0 pseudogene 4 (RPLP0P4) is a **processed pseudogene** found in the human genome. It shares sequence similarity with the functional gene encoding the 60S ribosomal protein lateral stalk subunit P0 (RPLP0), a component of the large ribosomal subunit involved in protein synthesis. However, RPLP0P4 does not produce a functional protein, and there is no evidence supporting its role as a protein-coding gene, therapeutic target, or disease-associated gene in humans. Most ribosomal protein genes have multiple pseudogenes scattered throughout the genome, which are generally considered non-functional remnants of evolutionary processes. RPLP0 (the parental gene) encodes a component of the ribosomal P-stalk in the 60S ribosomal subunit; it is essential for ribosome function and protein synthesis, but pseudogenes like RPLP0P4 do not contribute to this activity. RPLP0P4 is identified in gene databases as a processed pseudogene and does not encode any known protein product or serve as a biomarker or drug target. Conservation of some pseudogenes suggests possible regulatory roles in certain cases, but for RPLP0P4, no such functions are reported or validated in the current literature. RPLP0P4 is correctly described as a pseudogene of the ribosomal protein lateral stalk subunit P0, has no protein-coding function, is not a druggable target, and has no confirmed role in disease, therapy, or as a biomarker.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein lateral stalk subunit P0 pseudogene 4 (RPLP0P4).